S. Krishnan-Natesan

Current and Future Therapeutic Options in the Management of Invasive Aspergillosis

P. Chandrasekar, S. Krishnan-Natesan, 2012, Drugs.

In vitro Melanin Inhibition and/or alb1 Mutations Modify Azole Susceptibility in Aspergillus flavus

Wenjuan Wu, Philip J McDonald, S. Krishnan-Natesan, 2016 .

A comparison of the fungicidal activity of amphotericin B and posaconazole against Zygomycetes in vitro.

G. Alangaden, E. Manavathu, P. Chandrasekar, 2009, Diagnostic microbiology and infectious disease.

Terbinafine: a pharmacological and clinical review

S. Krishnan-Natesan, 2009, Expert opinion on pharmacotherapy.

Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.

G. Alangaden, E. Manavathu, P. Chandrasekar, 2008, International journal of antimicrobial agents.

Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.

E. Manavathu, P. Chandrasekar, S. Revankar, 2008, Diagnostic microbiology and infectious disease.

Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model.

E. Manavathu, J. Cutright, P. Chandrasekar, 2010, International journal of antimicrobial agents.

Concurrent reactivation of VZV and HSV-2 in a patient with uncontrolled Diabetes Mellitus: a case report

Philip J McDonald, S. Krishnan-Natesan, 2017 .

In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.

P. Chandrasekar, Wenjuan Wu, S. Krishnan-Natesan, 2012, Diagnostic microbiology and infectious disease.